API

**Thonzylamine HCl: Efficacious Antihistamine for Allergic Relief** Thonzylamine HCl, offered under the REFARMED CHEMICALS brand, is a potent first-generation antihistamine tailored for the pharmaceutical industry's demand for reliable and effective allergy symptomatic treatment. This compound, classified under the alkylamine class, serves as a crucial ingredient for medications formulated to alleviate discomfort from common allergic reactions such as hay fever, allergic rhinitis, and hives. As an active pharmaceutical ingredient (API), it plays a significant role in delivering relief to countless individuals affected by these prevalent conditions. Primarily presented as a white to slightly yellowish crystalline powder, Thonzylamine HCl upholds a high standard of purity, with an assay value ranging from 98.5% to 101.0%. Its manufacturing process is governed by stringent EU GMP certifications, ensuring that every batch meets the requirements for quality and consistency—attributes of paramount importance for our corporate clientele. Thonzylamine HCl works by effectively intercepting histamine's action—an organic compound responsible for numerous allergic symptoms. By blocking histamine receptors, this API diminishes the intensity of effects such as sneezing, runny nose, and itchy eyes, dramatically improving quality of life for allergy sufferers. Administered orally, the recommended dosage for adults and children over the age of 12 is between 50-100 mg, three to four times daily, as prescribed by healthcare professionals. Furthermore, precautions are advised in patients with liver or kidney disease, and the substance should be avoided by individuals with sensitivities to its components or conditions like acute asthma, narrow-angle glaucoma, or urinary retention. Additionally, users should be cautious about engaging in activities requiring cognitive sharpness, such as operating machinery or driving, as Thonzylamine HCl has sedative properties that may impair alertness. Our website offers complete details, including the chemical structure (2-[(2-Dimethylaminoethyl)(p-methoxybenzyl)amino]pyridine hydrochloride) and analytical specifications that reveal its physical and chemical properties. Rest assured, partnering with our company provides you with access to an essential product that epitomizes the excellence and dedication to the pharmaceutical supply chain, delivering health and wellness to the community.

Products still subject to third-party patent protection might be available solely for R&D purposes.

REFARMED CHEMICALS presents RamoseTron HCl, a high-purity pharmaceutical agent that serves as a critical component in mitigating the discomforting side effects associated with cancer treatments. Primarily utilized for its antiemetic properties, RamoseTron HCl is an effective serotonin (5-HT3) receptor antagonist, specifically formulated to prevent and treat nausea and vomiting induced by chemotherapy and radiation therapy. This product showcases our commitment to improving patient care during the rigorous journey of cancer treatment. RamoseTron HCl exhibits a remarkable ability to bind and block 5-HT3 receptors both in the gastrointestinal tract and the central nervous system—areas pivotal in cueing nausea and vomiting. By interrupting the signal transmission that triggers these adverse reactions, RamoseTron HCl lessens the severity and frequency of these symptoms, providing patients with much-needed relief. Tailored for adults and adolescents, RamoseTron HCl is administered orally or intravenously, dosed accordingly to align with the intensity of the emetogenic chemotherapy protocols. It ensures a rapid absorption with an extensive distribution throughout the body, assuring efficacy. The product is presented as a white to slightly yellowish-white crystalline powder, notable for its solubility in methanol, water, and ethanol—making it versatile for various pharmaceutical formulations. It meets rigorous quality standards, with certifications such as EU GMP, affirming its adherence to the highest production protocols. While offering substantial aid to cancer patients, healthcare providers must be attentive to possible contraindications and exercise caution in patients with specific medical conditions. Adverse effects, while generally manageable, must also be considered in the comprehensive patient care plan. REFARMED CHEMICALS' RamoseTron HCl is more than a medicine; it is a supportive ally for patients and healthcare providers in the fight against cancer and its challenging treatment side effects. Our product’s detailed specifications, as seen in the provided image, underscore our commitment to transparency and quality assurance.

Products still subject to third-party patent protection might be available solely for R&D purposes.

Refarmed Chemicals takes pride in providing the pharmaceutical industry with high-quality Ticlopidine Hydrochloride, an essential antiplatelet medication used to prevent strokes and other significant blood clots in patients who have experienced a stroke or transient ischemic attack (TIA). Manufactured under stringent GMP certification, our Ticlopidine Hydrochloride is presented in tablet form, with a strength of 250 mg ensuring consistent dosing and efficacy. Our Ticlopidine Hydrochloride acts by hindering platelet function, thereby diminishing the aggregation essential to blood clot formation. This preventive approach serves as a critical intervention in the management of clot-related disorders, significantly improving patient outcomes. Physicians typically recommend a starting dose of 250 mg administered twice daily, emphasizing that food intake during administration reduces gastrointestinal discomfort. Monitoring patient response allows for personalized treatment adjustments to optimize therapeutic benefits while considering safety profiles. As with all pharmaceuticals, we duly note possible side effects, ranging from mild gastrointestinal issues to less common, yet more severe reactions like neutropenia or liver impairment. This necessitates caution in prescribing to populations with liver disease, a history of bleeding disorders, or inflammatory bowel disease. Continuous patient monitoring and drug interaction vigilance are paramount, especially concerning commonly used medications such as aspirin and warfarin. Compliant storage conditions entail keeping the Ticlopidine Hydrochloride tablets at room temperature (15°C to 30°C), shielded from light and moisture to maintain product integrity. Ticlopidine Hydrochloride is supplied as a generic medication, ensuring affordability without compromising quality. Embracing our commitment to patient safety and treatment adherence, we underline the significance of medical guidance before initiating or discontinuing use, with particular respect to special populations like pregnant or breastfeeding women. Rest assured, our partnership with the DKSH Group underlines a shared vision for growth and delivery of quality healthcare solutions that spans across Asia and beyond, cementing our position as a trusted supplier in the pharmaceutical landscape.

Products still subject to third-party patent protection might be available solely for R&D purposes.

Tulobuterol base is a high-grade bronchodilator, primarily used for managing respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). This potent pharmaceutical ingredient is engineered to target and activate beta-2 adrenoreceptors in the airways, resulting in the relaxation of bronchial smooth muscles and effective bronchodilation. Refarmed Chemicals, a key player in the pharmaceutical industry and now part of the DKSH Group, manufactures Tulobuterol base with a commitment to excellence, as evidenced by compliance with EU GMP certifications and stringent quality controls. The product is presented as a white crystalline powder, with its consistency and purity validated by a comprehensive series of tests including IR, HPLC, and TLC tests. At the onset of use, Tulobuterol base exhibits rapid action within 5-15 minutes and sustains its therapeutic effect for up to 6 hours. Its main application is for the relief and prevention of bronchospasm in patients, thereby improving airway obstruction and lung function. Administered via an aerosol inhaler or nebulizer, dosage and frequency are tailored to individual patient needs and disease severity. The product's reliability is reinforced by its exhaustive assay, showing a 98.5% - 102% active ingredient range, with controlled levels of impurities and residual solvents. Safety is a core aspect of Tulobuterol base's design, having been tested for adverse components. Common side effects may include tachycardia and nervousness, among others. Caution is advised for patients with cardiovascular disease, hypertension, and diabetes. Tulobuterol base is contraindicated for individuals with hypersensitivity to beta-adrenergic agonists, those with thyrotoxicosis or tachyarrhythmias, and it is not recommended for use in children under 12 years of age. As with all medications, potential drug interactions need to be considered, notably with beta-blockers and other beta-adrenergic agonists. This product serves as a testament to Refarmed Chemicals' dedication to providing superior pharmaceutical materials. Through their integration with DKSH, they strive to deliver growth in Asia and beyond, ensuring the availability of quality medical compounds to healthcare providers and patients worldwide.

Products still subject to third-party patent protection might be available solely for R&D purposes.